Some authors have found that SLNs, which were loaded with doxorubicin, were able to overcome P-glycoprotein (Pgp)-mediated multidrug resistance (MDR), both in vitro in resistant leukemia cells and in vivo in the murine leukemia mouse model [12,13]. Here, PGP is linked to leukemia.